In this Review Course at ACR Convergence 2024, Iain McInnes, PhD, FRCP, discussed some of the challenges of RA: Remission is drug maintained, multimorbidity abounds, treatment strategies can be complex, & prevention is not yet possible.
Search results for: FLARE
Systemic Lupus Erythematosus: A Complex, Multi-Challenging Disease
Reviewing the research presented at ACR Convergence 2024.
The 2024 ARP President’s & Merit Awards
ARP members honored for significant contributions to rheumatology research, education and patient care.
Collaborative Care Essential for Diagnosis & Care of Neurosarcoidosis
At a ACR Convergence 2024 session, experts discussed key characteristics, diagnostic challenges & treatment considerations for neurosarcoidosis.
Toward Personalized Medicine in Pediatric Lupus
At this ACR Convergence 2024 session, discussion centered on novel techniques that offer hope for developing personalized therapies for pediatric SLE.
Lupus Nephritis Guideline Encourages Triple Therapy
Screening recommendations, triple therapy and more—here are insights into the upcoming ACR guideline for the care and treatment of patients with lupus nephritis.
Top Research in Gout from ACR Convergence 2024 at a Glance
Dr. Lisa Stamp helps filter the noise to get to the key insights from the research abstracts on gout presented at ACR Convergence 2024.
SURF’n Autoinflammation: Evaluation & Management of Syndrome of Undifferentiated Recurrent Fever
At this ACR Convergence 2024 session, the focus was on the identification & treatment of a newly identified syndrome of undifferentiated recurrent fever (SURF).
Advancements in Imaging
Experts shared insights into their work on building consensus for the use of musculoskeletal ultrasound for the diagnosis and management of RA and PsA.
Better Education on Gout
Experts addressed how education and follow-up for patients with gout can improve disease management and highlighted the need for a better construction of gout remission.
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 70
- Next Page »